Correlation Between StageZero Life and Cardiol Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both StageZero Life and Cardiol Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining StageZero Life and Cardiol Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between StageZero Life Sciences and Cardiol Therapeutics Class, you can compare the effects of market volatilities on StageZero Life and Cardiol Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in StageZero Life with a short position of Cardiol Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of StageZero Life and Cardiol Therapeutics.

Diversification Opportunities for StageZero Life and Cardiol Therapeutics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between StageZero and Cardiol is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding StageZero Life Sciences and Cardiol Therapeutics Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardiol Therapeutics and StageZero Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on StageZero Life Sciences are associated (or correlated) with Cardiol Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardiol Therapeutics has no effect on the direction of StageZero Life i.e., StageZero Life and Cardiol Therapeutics go up and down completely randomly.

Pair Corralation between StageZero Life and Cardiol Therapeutics

Assuming the 90 days trading horizon StageZero Life is expected to generate 2.11 times less return on investment than Cardiol Therapeutics. In addition to that, StageZero Life is 1.24 times more volatile than Cardiol Therapeutics Class. It trades about 0.02 of its total potential returns per unit of risk. Cardiol Therapeutics Class is currently generating about 0.06 per unit of volatility. If you would invest  120.00  in Cardiol Therapeutics Class on September 4, 2024 and sell it today you would earn a total of  99.00  from holding Cardiol Therapeutics Class or generate 82.5% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy99.66%
ValuesDaily Returns

StageZero Life Sciences  vs.  Cardiol Therapeutics Class

 Performance 
       Timeline  
StageZero Life Sciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days StageZero Life Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, StageZero Life is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.
Cardiol Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cardiol Therapeutics Class has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

StageZero Life and Cardiol Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with StageZero Life and Cardiol Therapeutics

The main advantage of trading using opposite StageZero Life and Cardiol Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if StageZero Life position performs unexpectedly, Cardiol Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardiol Therapeutics will offset losses from the drop in Cardiol Therapeutics' long position.
The idea behind StageZero Life Sciences and Cardiol Therapeutics Class pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments